Arkolith/Insider Trading/TSBX/Form 4

Versant Venture Capital V, L.P.

10% OwnerTurnstone Biologics Corp. (TSBX) · full profile →Form 4 · filed Jul 27, 2023
Net Buying
Open-Market Buys
$2.7M
Open-Market Sells
$0
Net Open-Market Flow
$2.7M
Transactions
26
9 non-derivative · 17 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2023Conversion(C)192K——192K
Jul 25, 2023Conversion(C)84K——84K
Jul 25, 2023Conversion(C)76K——76K
Jul 25, 2023Conversion(C)275K——275K
Jul 25, 2023Buy(P)197K$12.00$2.4M2.7M
Jul 25, 2023Buy(P)15K$12.00$180K207K
Jul 25, 2023Buy(P)7K$12.00$79K91K
Jul 25, 2023Buy(P)6K$12.00$71K82K
Jul 25, 2023Conversion(C)2.5M——2.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 25, 2023Conversion(C)601K—$00
Jul 25, 2023Conversion(C)7.9M—$00
Jul 25, 2023Conversion(C)118K—$00
Jul 25, 2023Conversion(C)263K—$00
Jul 25, 2023Conversion(C)238K—$00
Jul 25, 2023Conversion(C)3.5M—$00
Jul 25, 2023Conversion(C)2.2M—$00
Jul 25, 2023Conversion(C)34K—$00
Jul 25, 2023Conversion(C)37K—$00
Jul 25, 2023Conversion(C)85K—$00
Jul 25, 2023Conversion(C)1.1M—$00
Jul 25, 2023Conversion(C)230K—$00
Jul 25, 2023Conversion(C)255K—$00
Jul 25, 2023Conversion(C)582K—$00
Jul 25, 2023Conversion(C)269K—$00
Jul 25, 2023Conversion(C)106K—$00
Jul 25, 2023Conversion(C)7.7M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-043527) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML